| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |